Completed OBSERVATIONAL NCT01855659

A Single-center Study to Assess Peak Inspiratory Flow (PIF) in Different Stages' COPD Patients by Using the In-check Method. (INSPIRE)

Sponsor: Elpen Pharmaceutical Co. Inc.

Updated 6 times since 2017 Last updated: Dec 2, 2013 Started: Jun 30, 2013 Primary completion: Nov 30, 2013 Completion: Nov 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Pulmonary Disease and is currently completed. Elpen Pharmaceutical Co. Inc. leads this study, which shows 6 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Elpen Pharmaceutical Co. Inc.

Data source: Elpen Pharmaceutical Co. Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Athens, Greece